Agenda

A focus on kidney, bladder, and renal cancers.

The World GU’s multidisciplinary thought leaders will present the latest insights, debate hot topics, and participate in panel discussions and audience Q&As.

View Invited Faculty

Thursday | August 21

Poster Session & Welcome Reception
  • 6:00 PM - 9:00 PM
  • Curb Conservatory & Hall of Fame Rotunda

Friday | August 22

Breakfast Symposium (Non-CE)
  • Event Hall
  • SESSION 1
  • CMA Theater

Advancements in Imaging and Treatment Planning in GU Cancers ​

  • 8:45 AM - 9:05 AM
Theranostics in Prostate
  • 9:05 AM - 9:25 AM
How do you Define Locally Advanced Bladder Cancer?
Diagnosis and Management of Indeterminant Metastasis in Kidney Cancer
Panel Discussion and Q&A
Networking Break
  • Grand Foyer
  • SESSION 2
  • CMA Theater

Managing Early-Stage Disease

Early-Stage Kidney: Surgery, Ablation and Active Surveillance
Early-Stage Bladder: The Evolving Landscape
Early-Stage Prostate: Novel Diagnostics, Focal Therapy & Active Surveillance
Radiation Chip Shots: Small Tumors and Localized Disease
Panel Discussion and Q&A
Lunch Symposium (Non-CE)
  • Event Hall
  • SESSION 3
  • CMA Theater

Case-Based Real-World Management and Therapeutic Interventions in GU Cancers- Part I

Case-Based Approach to Oligometastatic Renal Disease
Case-Based Approach to Locally Advanced Bladder Cancer
The Current State of mHSPC: Volume of Disease and Treatment Management
Risk Stratification and Future Developments in Precison Management of Prostate Cancer
Panel Discussion and Q&A
Networking Break
  • Grand Foyer
  • SESSION 4
  • CMA Theater

Multidisciplinary Care of High-Risk Patients in GU Cancers

Point/Counterpoint: High-Risk Kidney Cancer
Point/Counterpoint: High-Risk Prostate Cancer
Point/Counterpoint: High-Risk Bladder Cancer
Panel Discussion and Q&A
  • SESSION 5
  • CMA Theater

Classifying and Managing Rare Histologies Across GU Cancers

Classifying Rare Histologies
How do you Manage Rare Bladder Histologies?
Managing Upper Tract Urothelial Carcinoma
Management of Rare Kidney Histologies
Panel Discussion and Q&A
  • SESSION 4
  • CMA Theater

Keynote Presentation (Non-CE)

Saturday | August 23

Breakfast Symposium (Non-CE)
  • Event Hall
  • SESSION 7
  • CMA Theater

Tool's for Tomorrow's Oncologist

Role of Precision Medicine
Trials in Progress in Early-Stage Therapeutics
Patient Frailty/FIT Levels
Palliative Care & Decision Making
Healthcare Policy
Implementing Pathways in an Evolving Landscape
Q&A
Networking Break
  • Grand Foyer
  • SESSION 8
  • CMA Theater

Strategies for the Implementation of MRD in GU Cancers

Defining MRD
Strategies for Implementing MRD
What's Different in Prostate?
Why can’t we Measure MRD in Kidney?
Panel Discussion and Q&A
Lunch Symposium (Non-CE)
  • Event Hall
  • SESSION 9
  • CMA Theater

Case-Based Real-World Management and Therapeutic Interventions in GU Cancers- Part 2

Case-based Approach to PARP ihibitors in Prostate Cancer
Case-based Approach to Kidney Cancer
Bladder MIBC Systemic Therapy and Outcomes
Panel Discussion and Q&A
  • SESSION 10
  • CMA Theater

Early-Stage Therapeutics: New Drugs in the Contemporary Landscape

Emerging Approaches to Bladder Cancer
Emerging Approaches to Prostate Cancer
Emerging Approaches to Kidney Cancer
NCI Intramural Prostate Cancer Studies
Q&A
Networking Break
  • Grand Foyer
  • SESSION 11
  • CMA Theater

Applying the Good News into Everyday Practice

Panel Discussion
  • SESSION 12
  • CMA Theater

Final GUpardy!

Farewell Reception

  • Event Hall
Let's join the biggest marketing conference on 2022.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Discover more
2025 World GU Conference
Icon_globe-2 X-twitter

© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.